{Reference Type}: Journal Article
{Title}: Isotretinoin as a promising option in the treatment of facial papules of frontal fibrosing alopecia.
{Author}: Beyzaee AM;Babaei M;Ghoreishi B;Waśkiel-Burnat A;Rudnicka L;Starace M;Tosti A;Patil A;Sinclair R;Goldust M;Rahmatpour Rokni G;
{Journal}: Int J Dermatol
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jul 11
{Factor}: 3.204
{DOI}: 10.1111/ijd.17356
{Abstract}: Frontal fibrosing alopecia (FFA) is a primary cicatricial alopecia characterized by hairline recession, pruritus, and facial papules (FP). Various therapies are used to stabilize disease activity and induce remission. However, FP of FFA is resistant to treatment in many cases. In this review, we searched the PubMed and Google Scholar databases to screen the published literature on treatment options for FP in the context of FFA. Overall, 12 studies were included in this review. Available literature suggests a noticeable improvement in resistant-to-treatment FP in FFA patients with oral isotretinoin. The available evidence is limited and is derived from retrospective studies and case reports/series. Systemic isotretinoin can be considered a promising therapeutic regimen for treating resistant-to-treatment FP of FFA patients. However, more extensive, well-designed studies are necessary for confirmatory evidence.